List of Tables:
Table 1. Snapshot of North America Single Cell Multiomics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Comparison of Rare Disease in Different Countries 32
Table 5. World Health Spending by Region, $ bn, 2013-2020 34
Table 6. Main Product Trends and Market Opportunities in North America Single Cell Multiomics Market 38
Table 7. North America Single Cell Multiomics Market by Product Type, 2021-2031, $ mn 46
Table 8. North America Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 51
Table 9. North America Single Cell Multiomics Market by Application, 2021-2031, $ mn 57
Table 10. North America Single Cell Multiomics Market: Clinical Research by Type, 2021-2031, $ mn 60
Table 11. North America Single Cell Multiomics Market by Sample Type, 2021-2031, $ mn 69
Table 12. North America Single Cell Multiomics Market: Human Samples by Type, 2021-2031, $ mn 72
Table 13. North America Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 80
Table 14. North America Single Cell Multiomics Market: Single-Cell Isolation and Dispensing by Technology, 2021-2031, $ mn 83
Table 15. North America Single Cell Multiomics Market: Single-Cell Analysis by Technology, 2021-2031, $ mn 92
Table 16. North America Single Cell Multiomics Market by End User, 2021-2031, $ mn 98
Table 17. North America Single Cell Multiomics Market by Country, 2021-2031, $ mn 105
Table 18. U.S. Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 109
Table 19. U.S. Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 109
Table 20. U.S. Single Cell Multiomics Market by End User, 2021-2031, $ mn 109
Table 21. Canada Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 111
Table 22. Canada Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 111
Table 23. Canada Single Cell Multiomics Market by End User, 2021-2031, $ mn 111
Table 24. Mexico Single Cell Multiomics Market by Omics Type, 2021-2031, $ mn 113
Table 25. Mexico Single Cell Multiomics Market by Workflow, 2021-2031, $ mn 113
Table 26. Mexico Single Cell Multiomics Market by End User, 2021-2031, $ mn 113
Table 27. 10x Genomics, Inc.: Company Snapshot 118
Table 28. 10x Genomics, Inc.: Business Segmentation 119
Table 29. 10x Genomics, Inc.: Product Portfolio 119
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America Single Cell Multiomics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of North America Single Cell Multiomics Market 27
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 30
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-2019 31
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 11. Primary Restraints and Impact Factors of North America Single Cell Multiomics Market 35
Figure 12. Investment Opportunity Analysis 39
Figure 13. Porters Fiver Forces Analysis of North America Single Cell Multiomics Market 42
Figure 14. Breakdown of North America Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue 47
Figure 15. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 47
Figure 16. North America Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn 48
Figure 17. North America Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn 49
Figure 18. North America Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn 50
Figure 19. Breakdown of North America Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue 52
Figure 20. North America Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%) 52
Figure 21. North America Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn 53
Figure 22. North America Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn 54
Figure 23. North America Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn 55
Figure 24. North America Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn 56
Figure 25. Breakdown of North America Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue 58
Figure 26. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 58
Figure 27. North America Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn 59
Figure 28. North America Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn 61
Figure 29. North America Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn 62
Figure 30. North America Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn 63
Figure 31. North America Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn 64
Figure 32. North America Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn 65
Figure 33. North America Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn 66
Figure 34. North America Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn 67
Figure 35. North America Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn 68
Figure 36. Breakdown of North America Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue 70
Figure 37. North America Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 70
Figure 38. North America Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn 71
Figure 39. North America Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn 73
Figure 40. North America Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn 74
Figure 41. North America Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn 75
Figure 42. North America Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn 76
Figure 43. North America Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn 77
Figure 44. North America Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn 78
Figure 45. North America Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn 79
Figure 46. Breakdown of North America Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue 81
Figure 47. North America Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%) 81
Figure 48. North America Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn 82
Figure 49. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn 84
Figure 50. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn 85
Figure 51. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn 86
Figure 52. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn 87
Figure 53. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn 88
Figure 54. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn 89
Figure 55. North America Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn 90
Figure 56. North America Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn 91
Figure 57. North America Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn 93
Figure 58. North America Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn 94
Figure 59. North America Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn 95
Figure 60. North America Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn 96
Figure 61. North America Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn 97
Figure 62. Breakdown of North America Single Cell Multiomics Market by End User, 2021-2031, % of Revenue 98
Figure 63. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 99
Figure 64. North America Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn 100
Figure 65. North America Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn 101
Figure 66. North America Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 102
Figure 67. North America Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn 103
Figure 68. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue 105
Figure 69. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 106
Figure 70. U.S. Single Cell Multiomics Market, 2021-2031, $ mn 108
Figure 71. Canada Single Cell Multiomics Market, 2021-2031, $ mn 110
Figure 72. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn 112
Figure 73. Growth Stage of North America Single Cell Multiomics Industry over the Forecast Period 114
